Ion-Pairing Contribution to the Liposomal Transport of Topotecan as Revealed by Mechanistic Modeling

J Pharm Sci. 2017 Apr;106(4):1149-1161. doi: 10.1016/j.xphs.2016.12.011. Epub 2016 Dec 20.

Abstract

Actively loaded liposomal formulations of anticancer agents have been widely explored due to their high drug encapsulation efficiencies and prolonged drug retention. Mathematical models to predict and optimize drug loading and release kinetics from these nanoparticle formulations would be useful in their development and may allow researchers to tune release profiles. Such models must account for the driving forces as influenced by the physicochemical properties of the drug and the microenvironment, and the liposomal barrier properties. This study employed mechanistic modeling to describe the active liposomal loading and release kinetics of the anticancer agent topotecan (TPT). The model incorporates ammonia transport resulting in generation of a pH gradient, TPT dimerization, TPT lactone ring-opening and -closing interconversion kinetics, chloride transport, and transport of TPT-chloride ion-pairs to describe the active loading and release kinetics of TPT in the presence of varying chloride concentrations. Model-based predictions of the kinetics of active loading at varying loading concentrations of TPT and release under dynamic dialysis conditions were in reasonable agreement with experiments. These findings identify key attributes to consider in optimizing and predicting loading and release of liposomal TPT that may also be applicable to liposomal formulations of other weakly basic pharmaceuticals.

Keywords: cancer; computational ADME; controlled release; ion-pairing; liposomes; mathematical model; nanoparticles; passive diffusion/transport; structure-transport relationship; zwitterion.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Biological Transport / physiology
  • Liposomes
  • Models, Chemical*
  • Topoisomerase I Inhibitors / chemistry
  • Topoisomerase I Inhibitors / metabolism
  • Topotecan / chemistry
  • Topotecan / metabolism*

Substances

  • Liposomes
  • Topoisomerase I Inhibitors
  • Topotecan